Frequency, Cost, and Influence Factors of Insulin Pen Needles Reuse for Patients with Diabetes in China

H. Li,Z. Ruan,X. D. Guan,Z. G. Guo,F. Sun,L. W. Shi

DOI: https://doi.org/10.1016/j.jval.2014.03.1440

IF: 5.156

2014-01-01

Value in Health

Abstract:To investigate the frequency and cost of insulin pen needles reuse, and explore the factors that associated with needles reuse for insulin-treated diabetes patients in China. A questionnaire-based survey was conducted in 7 medical centres across China from June to September of 2012. Type 1 and type 2 diabetes patients treated with insulin were included in the study. The data were analysed by descriptive analysis, Spearman correlation analysis, K-W and M-W U test using SPSS 19.0. 592 eligible respondents (30 type 1 and 562 type 2 diabetes patients) were included. One single needle was used 10.57 times base on 5% trimmed mean (8 times in median). 89.2% of patients reuse needles and 60.5% reuse >6 times. Among type 1 and type 2 diabetes, needles use frequencies base on 5% trimmed mean were 7.19 times (6 times in median) and 10.76 times (9 times in median), reuse of needles were 86.7% and 89.4%, needles reuse>6 times were 36.7% and 61.7%, respectively. Annual cost of needles was 237.0 CNY, estimated by the needle price of 2013 (NovoFine 32GTip, Novo Nordisk). The cost would be 2504.9 CNY/year if needles were used 1 time only. Economics burden was the most important factor of needles reuse for 68.9% of patients. Needles reuse was statistically and positively associated with age, diabetes duration, number of complications, value of fasting blood glucose, insulin injections times and dose, and was negative associated with income, with P-value<0.05. Needles reuse for insulin injection was a common phenomenon in insulin-treated diabetes patients in China. Economic burden was the main reason of needles reuse. Other influencing factors of needles reuse included age, diabetes-related health status and insulin use.